258 related articles for article (PubMed ID: 15958576)
1. Targeted measles virus vector displaying echistatin infects endothelial cells via alpha(v)beta3 and leads to tumor regression.
Hallak LK; Merchan JR; Storgard CM; Loftus JC; Russell SJ
Cancer Res; 2005 Jun; 65(12):5292-300. PubMed ID: 15958576
[TBL] [Abstract][Full Text] [Related]
2. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus.
Anderson BD; Nakamura T; Russell SJ; Peng KW
Cancer Res; 2004 Jul; 64(14):4919-26. PubMed ID: 15256464
[TBL] [Abstract][Full Text] [Related]
3. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
[TBL] [Abstract][Full Text] [Related]
4. Differential receptor usage by measles virus strains.
Bartz R; Firsching R; Rima B; ter Meulen V; Schneider-Schaulies J
J Gen Virol; 1998 May; 79 ( Pt 5)():1015-25. PubMed ID: 9603316
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas.
Paraskevakou G; Allen C; Nakamura T; Zollman P; James CD; Peng KW; Schroeder M; Russell SJ; Galanis E
Mol Ther; 2007 Apr; 15(4):677-86. PubMed ID: 17299404
[TBL] [Abstract][Full Text] [Related]
6. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.
Blechacz B; Splinter PL; Greiner S; Myers R; Peng KW; Federspiel MJ; Russell SJ; LaRusso NF
Hepatology; 2006 Dec; 44(6):1465-77. PubMed ID: 17133484
[TBL] [Abstract][Full Text] [Related]
7. Recombinant measles viruses efficiently entering cells through targeted receptors.
Schneider U; Bullough F; Vongpunsawad S; Russell SJ; Cattaneo R
J Virol; 2000 Nov; 74(21):9928-36. PubMed ID: 11024120
[TBL] [Abstract][Full Text] [Related]
8. Intravascularly administered RGD-displaying measles viruses bind to and infect neovessel endothelial cells in vivo.
Ong HT; Trejo TR; Pham LD; Oberg AL; Russell SJ; Peng KW
Mol Ther; 2009 Jun; 17(6):1012-21. PubMed ID: 19277014
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker.
Peng KW; Donovan KA; Schneider U; Cattaneo R; Lust JA; Russell SJ
Blood; 2003 Apr; 101(7):2557-62. PubMed ID: 12433686
[TBL] [Abstract][Full Text] [Related]
10. A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice.
Combredet C; Labrousse V; Mollet L; Lorin C; Delebecque F; Hurtrel B; McClure H; Feinberg MB; Brahic M; Tangy F
J Virol; 2003 Nov; 77(21):11546-54. PubMed ID: 14557640
[TBL] [Abstract][Full Text] [Related]
11. V and C proteins of measles virus function as virulence factors in vivo.
Patterson JB; Thomas D; Lewicki H; Billeter MA; Oldstone MB
Virology; 2000 Feb; 267(1):80-9. PubMed ID: 10648185
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional studies of the measles virus hemagglutinin: identification of a novel site required for CD46 interaction.
Patterson JB; Scheiflinger F; Manchester M; Yilma T; Oldstone MB
Virology; 1999 Mar; 256(1):142-51. PubMed ID: 10087234
[TBL] [Abstract][Full Text] [Related]
13. A wild-type Japanese measles virus strain inducing predominant early down-regulation of CD46.
Sakata H; Kurita M; Murakami Y; Nagasawa S; Watanabe M; Ueda S; Matsumoto M; Sato T; Kobune F; Seya T
Biol Pharm Bull; 1998 Nov; 21(11):1121-7. PubMed ID: 9853398
[TBL] [Abstract][Full Text] [Related]
14. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
Sugiyama T; Yoneda M; Kuraishi T; Hattori S; Inoue Y; Sato H; Kai C
Gene Ther; 2013 Mar; 20(3):338-47. PubMed ID: 22717740
[TBL] [Abstract][Full Text] [Related]
15. Engineered measles virus as a novel oncolytic therapy against prostate cancer.
Msaouel P; Iankov ID; Allen C; Morris JC; von Messling V; Cattaneo R; Koutsilieris M; Russell SJ; Galanis E
Prostate; 2009 Jan; 69(1):82-91. PubMed ID: 18973133
[TBL] [Abstract][Full Text] [Related]
16. Targeted release of oncolytic measles virus by blood outgrowth endothelial cells in situ inhibits orthotopic gliomas.
Wei J; Wahl J; Nakamura T; Stiller D; Mertens T; Debatin KM; Beltinger C
Gene Ther; 2007 Nov; 14(22):1573-86. PubMed ID: 17898797
[TBL] [Abstract][Full Text] [Related]
17. Genetic changes that affect the virulence of measles virus in a rhesus macaque model.
Bankamp B; Hodge G; McChesney MB; Bellini WJ; Rota PA
Virology; 2008 Mar; 373(1):39-50. PubMed ID: 18155263
[TBL] [Abstract][Full Text] [Related]
18. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter.
Dingli D; Peng KW; Harvey ME; Greipp PR; O'Connor MK; Cattaneo R; Morris JC; Russell SJ
Blood; 2004 Mar; 103(5):1641-6. PubMed ID: 14604966
[TBL] [Abstract][Full Text] [Related]
19. Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2.
Manchester M; Gairin JE; Patterson JB; Alvarez J; Liszewski MK; Eto DS; Atkinson JP; Oldstone MB
Virology; 1997 Jun; 233(1):174-84. PubMed ID: 9201227
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus.
Murakami Y; Seya T; Kurita M; Fukui A; Ueda S; Nagasawa S
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1351-9. PubMed ID: 9494106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]